Ticilimumab
Ticilimumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Ticilimumab is under investigation for the treatment of Mesothelioma, Liver Cancer, Liver Neoplasms, Liver Cell Caricinoma, and HepatoCellular Carcinoma. Ticilimumab has been investigated in Part C: Malignant Mesothelioma and Part A and B: Advanced Solid Malignancies.
| Trade Name | Ticilimumab |
| Generic | Tremelimumab |
| Tremelimumab Other Names | Ticilimumab, Tremelimumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Ticilimumab
